Covered recipient · General Payments record
JOHN KEITH MILLER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,362.05
- Reported across 137 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $375.16 | 20 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $131.28 | 6 |
| PFIZER INC. | $37.46 | 2 |
| Xeris Pharmaceuticals, Inc. | $37.17 | 2 |
| AIMMUNE THERAPEUTICS, INC. | $30.03 | 2 |
| Corcept Therapeutics | $23.72 | 1 |
| Lilly USA, LLC | $21.36 | 1 |
| Phathom Pharmaceuticals, Inc. | $17.26 | 1 |
| Merck Sharp & Dohme Corporation | $16.94 | 1 |
| Novo Nordisk AS | $16.55 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $15.12 | 1 |
| Amgen Inc. | $14.18 | 1 |
| GlaxoSmithKline, LLC. | $14.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (20)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.10 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105037277 | CMS |
| ABBVIE INC. | $12.94 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105037279 | CMS |
| ABBVIE INC. | $19.25 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105037281 | CMS |
| ABBVIE INC. | $33.93 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105037283 | CMS |
| ABBVIE INC. | $10.66 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105037285 | CMS |
| ABBVIE INC. | $32.40 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105037287 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $14.91 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147020363 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $15.12 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147001901 | CMS |
| Amgen Inc. | $14.18 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111652677 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $15.12 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086259180 | CMS |
| Corcept Therapeutics | $23.72 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117772225 | CMS |
| GlaxoSmithKline, LLC. | $14.09 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116688011 | CMS |
| Lilly USA, LLC | $21.36 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135069659 | CMS |
| Merck Sharp & Dohme LLC | $16.94 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141972207 | CMS |
| Novo Nordisk Inc | $16.55 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097534261 | CMS |
| PFIZER INC. | $18.05 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131320241 | CMS |
| PFIZER INC. | $19.41 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131938839 | CMS |
| Phathom Pharmaceuticals, Inc. | $17.26 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151097057 | CMS |
| Xeris Pharmaceuticals, Inc. | $20.99 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144599374 | CMS |
| Xeris Pharmaceuticals, Inc. | $16.18 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144599376 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.